Genexa Jet Lag Tablet, Chewable
NDC Package 69676-0047-1
Package Information
Genexa Jet Lag (arnica montana, cinchona officinalis, cocculus indicus, coffea cruda, tabacum) tablets is uses*addresses symptoms associated with jet lag. This formulation utilizes a tablet, chewable delivery system. Marketed by Genexa Inc., this product is identified by NDC 69676-0047.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 69676 - Genexa Inc.
- 69676-0047 - Genexa Jet Lag
- 69676-0047-1 - 1 BOTTLE, PLASTIC in 1 CARTON / 60 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
- 69676-0047 - Genexa Jet Lag
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69676-0047-1 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 60 tablet, chewable in 1 bottle, plastic of Genexa Jet Lag, a human over the counter drug labeled by Genexa Inc.. This tablet, chewable is formulated for oral use and contains anamirta cocculus seed; arabica coffee bean; arnica montana; cinchona officinalis bark; tobacco leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Genexa Inc. on November 04, 2021. The current certification is valid through December 31, 2026.
How is this Genexa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69676004701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.